GB2155176A - Sequencing DNA - Google Patents
Sequencing DNA Download PDFInfo
- Publication number
- GB2155176A GB2155176A GB08500960A GB8500960A GB2155176A GB 2155176 A GB2155176 A GB 2155176A GB 08500960 A GB08500960 A GB 08500960A GB 8500960 A GB8500960 A GB 8500960A GB 2155176 A GB2155176 A GB 2155176A
- Authority
- GB
- United Kingdom
- Prior art keywords
- dna
- sequencing
- gel
- aliquots
- different
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012163 sequencing technique Methods 0.000 title claims abstract description 47
- 238000000034 method Methods 0.000 claims abstract description 82
- 108020004414 DNA Proteins 0.000 claims abstract description 80
- 239000012634 fragment Substances 0.000 claims abstract description 37
- 238000001962 electrophoresis Methods 0.000 claims abstract description 22
- 238000001502 gel electrophoresis Methods 0.000 claims abstract description 6
- 238000012544 monitoring process Methods 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims description 46
- 229920002401 polyacrylamide Polymers 0.000 claims description 18
- 238000001712 DNA sequencing Methods 0.000 claims description 17
- 108091034117 Oligonucleotide Proteins 0.000 claims description 13
- 125000003277 amino group Chemical group 0.000 claims description 10
- 238000010521 absorption reaction Methods 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 8
- 238000004458 analytical method Methods 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 6
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 3
- 238000002144 chemical decomposition reaction Methods 0.000 claims 9
- 238000007385 chemical modification Methods 0.000 claims 3
- 102000053602 DNA Human genes 0.000 description 46
- 239000000499 gel Substances 0.000 description 27
- 239000000975 dye Substances 0.000 description 23
- 230000005284 excitation Effects 0.000 description 19
- 239000013615 primer Substances 0.000 description 15
- 238000001514 detection method Methods 0.000 description 13
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 230000002285 radioactive effect Effects 0.000 description 6
- 238000000211 autoradiogram Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000012300 Sequence Analysis Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 230000031700 light absorption Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 102000004594 DNA Polymerase I Human genes 0.000 description 3
- 108010017826 DNA Polymerase I Proteins 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 108020004511 Recombinant DNA Proteins 0.000 description 3
- 108020004682 Single-Stranded DNA Proteins 0.000 description 3
- 230000008033 biological extinction Effects 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
- 230000037230 mobility Effects 0.000 description 3
- 239000002777 nucleoside Substances 0.000 description 3
- -1 rhodamine isothiocyanate Chemical class 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- SGAOZXGJGQEBHA-UHFFFAOYSA-N 82344-98-7 Chemical compound C1CCN2CCCC(C=C3C4(OC(C5=CC(=CC=C54)N=C=S)=O)C4=C5)=C2C1=C3OC4=C1CCCN2CCCC5=C12 SGAOZXGJGQEBHA-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- OAICVXFJPJFONN-OUBTZVSYSA-N Phosphorus-32 Chemical compound [32P] OAICVXFJPJFONN-OUBTZVSYSA-N 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000000376 autoradiography Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- XHXYXYGSUXANME-UHFFFAOYSA-N eosin 5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 XHXYXYGSUXANME-UHFFFAOYSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229940097886 phosphorus 32 Drugs 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 238000006862 quantum yield reaction Methods 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- WYNZXNXFHYJUTE-UHFFFAOYSA-N 1,2-dioxetanedione Chemical compound O=C1OOC1=O WYNZXNXFHYJUTE-UHFFFAOYSA-N 0.000 description 1
- OBYNJKLOYWCXEP-UHFFFAOYSA-N 2-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]-4-isothiocyanatobenzoate Chemical compound C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C1=CC(N=C=S)=CC=C1C([O-])=O OBYNJKLOYWCXEP-UHFFFAOYSA-N 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 230000007018 DNA scission Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000001132 aluminium potassium sulphate Substances 0.000 description 1
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000005546 dideoxynucleotide Substances 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000003203 nucleic acid sequencing method Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 239000000985 reactive dye Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000007019 strand scission Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
- G01N27/44721—Arrangements for investigating the separated zones, e.g. localising zones by optical means
- G01N27/44726—Arrangements for investigating the separated zones, e.g. localising zones by optical means using specific dyes, markers or binding molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
- G01N27/44721—Arrangements for investigating the separated zones, e.g. localising zones by optical means
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Electrochemistry (AREA)
- General Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
A method of sequencing DNA comprises sequencing the DNA by producing DNA fragments therefrom labelled with a colored or fluorescent tag, separating the fragments by gel electrophoresis and determining the relative positions of the fragments on the gel. This method may be effected utilising a system comprising: a source of tagged DNA fragments; a zone for containing an electrophoresis gel; means for introducing the tagged DNA fragments to said zone; and photometric means for monitoring said tagged DNA fragments as they move through said gel.
Description
SPECIFICATION
Sequencing DNA
The development of reliable methods for sequence analysis of DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) has been one of the keys to the success of recombinant DNA and genetic engineering.
When used with the other techniques of modern molecular biology, nucleic acid sequencing allows dissection and analysis of animal, plant, and viral genomes into discrete genes with defined chemical structure. Since the function of a biological molecule is determined by its structure, defining the structure of a gene is crucial to the eventual manipulation of this basic unit of hereditary information in useful ways.
Once genes can be isolated and characterized, they can be modified to produce desired changes in their structure that allow the production of gene products-- proteins--with different properties than those possessed by the original proteins. Microorganisms into which the natural or synthetic genes are placed can be used as chemical "factories" to produce large amounts of scarce human proteins such as interferon, growth hormone, and insulin. Plants can be given the genetic information to allow them to survive harsh environmental conditions or produce their own fertilizer.
The development of modern nucleic acid sequencing methods involved parallel developments in a variety of techniques. One was the emergence of simple and reliable methods for cloning small to medium-sized strands of DNA into bacterial plasmids, bacteriophages, and small animal viruses. This allowed the production of pure DNA in sufficient quantities to allow its chemial analysis. Another was the near perfection of gel electrophoretic methods for the high resolution separation of oligonucleotides on the basis of their size. The key conceptual development, however, was the introduction of methods of generating size-nested sets of fragments cloned, purified DNA that contain, in their collection of lengths, the information necessary to define the sequence of the nucleotides comprising the parent DNA molecules.Two distinct methods of generating these fragment sets are in widespread use, one developed by Sanger; Sanger, F., Nicklen, S. and
Coulson,A. R. Proc. Natl.Acad. Sci. USA74, 5463 (1977) and Smith, A. J. H. Methods in Enzymology65, 56-580 (1980); the other by Maxam and Gilbert; Maxam, A. M. and Gilbert, W. methods in Enzymology 65, 499-559 (1980).
The method developed by Sanger is referred to as the dideoxy chain termination method. In the most commonly used variation of this method, a DNA segment is cloned into a single-stranded DNA phage such as M13. These phage DNAs can serve as templates for the primed synthesis of the complementary strand by the Klenowfragment of DNA polymerase I. The primer is either a synthetic oligonucleotide or a restriction fragment isolated from the parental recombinant DNA that hybridizes specifically to a region of the M13 vector near the 3' end of the cloned insert. In each of four sequencing reactions, the primed synthesis is carried out in the presence of enough of the dideoxy analog of one of the four possible deoxynucleotides so that the growing chains are randomly terminated by the incorporation of these "dead-end" nucleotides.The relative concentration of dideoxy to deoxy forms is adjusted to give a spread of termination events corresponding to all the possible chain lengths that can be resolved by gel electophoresis. The products from each of the four primed synthesis reactions are then separated on individual tracks of polyacrylamide gels by the electrophoresis. Radioactive tags incorporated in the growing chains are used to develop an autoradiogram image of the pattern of the DNA in each electrophoresis track. The sequence of the deoxynucleotides in the cloned DNA is determined from an examination of the pattern of bands in the four lanes.
The method developed by Maxam and Gilbert uses chemical treatment of purified DNA to generate size-nested sets of DNA fragments analogous to those produced by the Sanger method. Single or double-stranded DNA, labeled with radioactive phosphate at either the 3' or 5' end, can be sequenced by this procedure. In four sets of reactions, cleavage is induced at one or two of the four nucleotide bases by chemical treatment. Cleavage involves a three-stage process: modification of the base, removal of the modified base from its sugar, and strand scission at that sugar. Reaction conditions are adjusted so that the majority of end-labeled fragments generated are in the size range (typically 1 to 400 nucleotides) that can be resolved by gel electrophoresis.The electrophoresis, autoradiography, and pattern analysis are carried out essentially as is done for the Sanger method. (Although the chemical fragmentation necessarily generates two pieces of DNA each time it occurs, only the piece containing the end label is detected on the autoradiogram.)
Both of these DNA sequencing methods are in widespread use, and each has several variations. For each, the length of sequence that can be obtained from a single set of reactions is limited primarily by the resolution of the polyacrylamide gels used for electrophoresis. Typically, 200 to 400 bases can be read from a single set of gel tracks. Although successful, both methods have serious drawbacks, problems associated primarily with the electrophoresis procedure. One problem is the requirement of the use of radiolabel as a tag for location of the DNA bands in the gels.One has to contend with the short half-life of phosphorus-32, and hence the instability of the radiolabeling reagents, and with the problems of radioactive disposal and handling. More importantly, the nature of autoradiography (the film image of a radioactive gel band is broader than the band itself) and the comparison of band positions between four different gel tracks (which may or may not behave uniformly in terms of band mobilities) can limit the observed resolution of bands and hence the length of sequence that can be read from the gels. In addition, the track-to-track irregularities make automated scanning of th autoradiograms difficult--the human eye can presently compensate for these irregularities much better than computers can. This need for manual "reading" of the autoradiograms is time-consuming, tedious and error-prone.Moreover, one cannot read the gel patterns while the electrophoresis is actually being performed, so as to be able to terminate the electrophoresis once resolution becomes insufficient to separate adjoining bands, but must terminate the electrophoresis at some standardized time and wait for the autoradiogram to be developed before the sequence reading can begin.
The present invention addresses these and other problems associated with the electrophoresis step in the
DNA sequencing procedures and is believed to represent a significant advance in the art.
Briefly, this invention comprises a novel process for the electrophoretic analysis of DNA fragments produced in DNA sequencing operations wherein a set of four chromophores or fluorophores are used to tag the DNA fragments produced by the sequencing chemistry and permit the detection and characterization of the fragments as they are resolved by electrophoresis through a gel. The detection employs an absorption or fluorescent photometer capable of monitoring the tagged bands as they are moving through the gei.
This invention also includes a novel system for the analysis of DNAfragments comprising:
a source of chromophore or fluorescent tagged DNA fragments, said fragments being differently tagged,
a zone for containing an electrophoresis gel,
means for introducing said tagged DNA fragments to said zone; and
photometric means for monitoring or detecting said tagged DNA fragments as they move through and are separated by said gel.
It is an object of this invention to provide a novel process for the sequence analysis of DNA.
It is another object of our invention to provide a novel system for the analysis of DNA fragments.
More particularly, it is an object of this invention to provide an improved process for the sequence analysis of DNA.
These and other objects and advantages of this invention will be apparent from the detailed description which follows taken in conjunction with the accompanying drawings.
Turning to the drawings:
Figure 1 is an illustration of one means of end-labeling a DNA fragment with a fluorescent tag. Pst. I and T4
DNA ligase are enzymes commonly used in recombinant DNA research.
Figure 2 is a block diagram of automated DNA sequencer, gel electrophoretic system.
Figure 3 is a schematic diagram of an optical configuration in the detector unit. P, lamp source; L1, objective lens; L2, collimating lens; F1, UV blocking filter; F2, heat blocking filter; F3, band pass excitation filter; F4, long pass emission filter; DM, dichroic mirror; C, polyacrylamide gel; PMT, photomultiplier tube.
Figure 4 is a schematic diagram of another optical configuration in the detector unit. F1 to F4 are bandpass filters centered at the emission maximum of the different dyes. P1 to P4 are photomultiplier tubes. The excitation light is of a wavelength such that it is not transmitted through any of the filters F1 to F4.
Figure 5 is a comparison of the type of data produced by DNA sequencing of the sequence shown in
Figure 1.
Figure 6 is a block diagram of a preferred DNA sequencer according to this invention.
Design of tagged primers for use with Sanger method
In the previous methods of DNA sequencing, including those based on the Sanger dideoxy chain termination method, a single radioactive label, phosphorus-32, is used to identify all bands on the gels. This necessitates that the fragment sets produced in the four synthesis reactions be run on separate gel tracks and leads to the problems associated with comparing band mobilities in the different tracks. This problem is overcome in the present invention by the use of a set of four chromophores or fluorophores with different absorption or fluorescent maxima, respectively. Each of these tags is coupled chemicaly to the primer used to initiate the synthesis of the fragment strands.In turn, each tagged primer is then paired with one of the dideoxynucleotides and used in the primed synthesis reaction with the Klenowfragment of DNA polymerase.
The primers must have the following characteristics. 1) They must have a free 3' hydroxyl group to allow chain extension by the polymerase. 2) They must be complementary to a unique region 3' of the cloned insert. 3) They must be sufficiently long to hybridize to form a unique, stable duplex. 4) The chromophore or fluorophore must not interfere with the hybridization or prevent 3'-end extension by the polymerase.
Conditions 1,2 and 3 above are satisfied by several synthetic oligonucleotide primers which are in general use for Sanger4ype sequencing utilizing M 13 vectors. One such primer is the 12 mer 5'TCA CGa CGT TGT 3' were A, C, G and T represent the four different nucleoside components of DNA; A, adenosine; C, cytosine; G, guanosine; T,thymidine.
The chemistry for the coupling of the chromophoric or fluorophoric tags is described in Application No.
8432205 filed 20th December 1984. The strategy used is to introduce an aliphatic amino group at the 5' terminus as the last addition in the synthesis of the oligonucleotide primer. This reactive amino group may then readily be coupled with a wide variety of amino reactive chromophores and/or fluorophores. This approach aids compatibility of the labeled primers with condition 4 above.
The four dyes used must have high extinction coefficients and/or reasonably high quantum yields for fluorescence. They must have well resolved absorption maxima and/or emission masima. A representative set of four such amino reactive dyes are: Ex isothiocyanage (FIT, Em
fluorescein isothiocyanage (FlTC, A = 495, x = 520, e495 ~ 8 x 104),
max max
eosin isothiocyanate (EITC, A = 522, Em = 543 E522 = 8 x
max max tetramethyl rhodamine isothiocyanate (TMRITC, Am = 550, = 578, E550 = 4 x 104), and
max max substituted rhodamine isothiocyanate (XRITC,hEX = 580, A = 604, 580 = 8 x104)
max max where A represents the wavelength in nanometers, Ex is excitation, Em is emission, max is maximum, and 8 is the molar extinction coefficient.
These dyes have been attached to the M13 primer and the conjugates electrophoresed on a 20% polyacrylamide gel. The labeled primers are visible by both their absorption and their fluorescence in the gel.
All four labeled primers have identical electrophoretic mobilities. The dye conjugated primers retain their ability to specifically hybridize to DNA, as demonstrated by their ability to replace the underivitized oligonucleotide normally used in the sequencing reactions.
End labeling of DNA for use with Maxam/Gilbert method
In the Maxam/Gilbert method of DNA sequencing, the end of the piece of DNA whose sequence is to be determined must be labeled. This is conventionaly done enzymatically using radioactive nucleosides. In order to use the Maxam/Gilbert method in conjunction with the dye detection scheme described in this invention, the DNA piece must be labeled with dyes. One manner in which this may be accomplished is shown in Figure 1. Certain restriction endonucleases generate what is known as a 3' overhang as the product of DNA cleavage. These enzymes generate a "sticky end," a short stretch of single stranded DNA at the end of a piece of double stranded DNA. This region will anneal with a complementary stretch of DNA, which may be covalentlyjoined to the duplex DNA with the enzyme ligase.In this manner one of the strands is covalently linked to a detectable moiety. This moiety may be a dye, an amino group or a protected amino group (which could be deprotected and reacted with dye subsequent to the chemical reactions).
Sequencing reactions
The dideoxy sequencing reactions are performed in the standard fashion Smith, A. J. H., Methods in
Enzymology 65, 56--580 (1980), except that the scale may be increased if necessary to provide an adequate signal intensity in each band for detection. The reactions are done using a different color primer for each different reaction, e.g., FlTC for the "A" reaction, ElTCforthe "C" reaction, TMRITC for the "G" reaction, and
XRITC for the "T" reaction. No radiolabeled nucleoside triphosphate need be included in the sequencing reaction.
The Maxam/Gilbert sequencing reactions are performed in the usual manner, Gill, S. F. Aldrichimica Acta 16(3), 59-61 (1983), except that the end label is either one or four colored dyes, or a free or protected amino group which may be reacted with dye subsequently.
Gel electrophoresis
Aliquots of the sequencing reactions are combined and loaded onto a 5% polyacrylamide column 10 shown in Figure 2 from the upper reservoir 12. The relative amounts of the four different reactions in the mixture are empirically adjusted to give approximately the same fluorescence or absorptive signal intensity from each of the dye DNA conjugates. This permits compensation for differences in dye extinction coefficients, dye fluorescence quantum yields, detector sensitivities and so on. A high voltage is placed across the column 10 so as to electrophorese the labeled DNA fragments through the gel. The labeled DNA segments differing in length by a single nucleotide are separated by electrophoresis in this gel matrix.At or nearthe bottom of the gel column 10, the bands of DNA are resolved from one another and pass through the detector 14 (more fully described in the next section). The detector 14 detects the fluorescent or chromophoric bands of DNA in the gel and determines their color, and therefore to which nucleotide they correspond. This information yields the DNA sequence.
Detection
There are many different ways in which the tagged molecules which have been separated by length using polyacrylamide gel electrophoresis may be detected. Four illustrative modes are described below. These are i) detection of the fluorescence excited by light of different wavelengths for the different dyes, ii) detection of fluorescence excited by light of the same wavelength for the different dyes, iii) elution of the molecules from the gel and detection by chemiluminescence, and iv) detection by the absorption of light by the molecules. In modes i) and ii) the fluorescence detector should fulfill the following requirements. a)
The excitation light beam should not have a height substantially greater than the height of a band. This is normally in the range of 0.1 to 0.5 mm.The use of such a narrow excitation beam allows the attainment of maximum resolution of bands. b) The excitation wavelength can be varied to match the absorption maxima of each of the different dyes or can be a single narrow, high intensity light band that excites all four fluorophores and does not overlap with any of the fluorescence emission. c) The optical configuration should minimize the flux of scattered and reflected excitation light to the photodetector 14.The optical filters to block out scattered and reflected excitation light are varied as the excitation wavelength is varied. d) The photodetector 14 should have a fairly low noise level and a good spectral response and quantum efficiency throughout the range of the emission of the dyes (500 to 600 nm for the dyes listed above). e) The optical system for collection of the emitted fluorescence should have a high numerical aperture. This maximizes the fluorescence signal. Furthermore, the depth of field of the collection optics should include the entire width of the column matrix.
Two illustrative fluorescence detection systems are diagrammed in Figures 3 and 4. The system in Figure 3 is compatible with either single wavelength excitation or multi wavelength excitation. For single wavelength excitation, the filter F4 is one of four band pass filters centered at the peak emission wavelength of each of the dyes. This filter is switched every few seconds to allow continual monitoring of each of the four fluorophores. For multi wavelength excitation, the optical elements F3 (excitation filter), DM (dichroic mirror), and F4 (barrierfilter) are switched together. In this manner both the excitation light and the observed emission light are varied. The system in Figure 4 is a good arrangement for the case of single wavelength excitation.This system has the advantage that no moving parts are required, and fluorescence from all four of the dyes may be simultaneously and continuously monitored. A third approach (iii above) to detection is to elute the labeled molecules at the bottom of the gel, combine them with an agent for excitation of chemiluminescence such as 1,2 dioxetane dione, Gill, S. K. Aidrichimica Acta 16(3), 59-61(1983); Mellbin, G.
J. Liq. Chrom. 6(9), 1603-1616(1983), and and flow the mixture directly into a detector which can measure the emitted light at four separate wavelengths (this detector is similar to that shown in Figure 4, but without a need for an excitation light source). The background signal in chemiluminescence is much lowerthan in fluorescene, resulting in higher signal to noise ratios and increased sensitivity. Finally, the measurement may be made by measurements of light absorption (iv above). In this case, a light beam of variable wavelength is passed through the gel, and the decrease in the beam intensity due to absorption of light by the labeled molecules is measured. By measuring the absorption of light at the different wavelengths corresponding to the absorption maximum of the four dyes, it is possible to determine which dye molecule is in the light path.A disadvantage of this type of measurement is that absorption measurements are inherently less sensitive than fluorescence measurements.
The above-described detection system is interfaced to a computer 16. In each time interval examined, the computer 16 receives a signal proportional to the measured signal intensity at that time for each of the four colored tags. This information tells which nucleotide terminates the DNA fragment of the particular length in the observation window at that time. The temporal sequence of colored bands gives the DNA sequence. In
Figure 5 is shown the type of data obtained by conventional methods, as well as the type of data obtained by the improvements described in this invention.
The following example is presented solely to ilustratethe invention.
Example
Figure 6 shows a block diagram of a DNA sequenator for use with one dye at a time. The beam (4880 ) from an argon ion laser 100 is passed into the polyacrylamide gel tube (sample) 102 by means of a beamsteerer 104. Fluorescence exited by the beam is collected using a low f-number lens 106, passed through an appropriate set of optical filters 108 and 110 to eliminate scattered excitation light and detected using a photomultiplier tube (PMT) 112. The signal is readily detected on a strip chart recorder. DNA sequencing reactions are carried out utilizing a fluorescein labeled oligonucleotude primer. The peaks on the chart correspond to fragments to fluorescein labeled DNA of varying lengths synthesized in the sequencing reactions and separated in the gel tube by electrophoresis. Each peak contains the order of 10-15to 10-16 moies ffluorescein, which is approximately equal to the amount of DNA obtained per band in an equivalent sequencing gel utilizing radioisotope detection. This proves that the fluorescent tag is not removed or degraded from the oligonucleotide primer in the sequencing reactions. It also demonstrates that the detection sensitivity is quite adequate to perform DNA sequence analysis by this means.
Claims (38)
1. A method of sequencing DNA, which method comprises sequencing the DNA by producing DNA fragments therefrom labelled with a colored or fluorescent tag, separating the fragments by gel electrophoresis and determining the relative positions of the fragments on the gel.
2. A method according to claim 1, wherein the sequencing is effected using the chain termination method.
3. A method according to claim 2, wherein a primer oligonucleotide is labelled with a colored tag.
4. A method according to claim 2, wherein a primer oligonucleotide is labelled with a fluorescent tag.
5. A method according to claim 1, wherein the sequencing is effected using the chemical degradation method.
6. A method according to claim 5, wherein the DNA to be analysed is labelled with a colored tag.
7. A method according to claim 5, wherein the DNA to be analysed is labelled with a fluorescent tag.
8. A method according to claim 5, wherein the DNA to be analysed is provided with an amino group at the 5'-terminus, which group is coupled to a dye molecule subsequent to the sequencing reactions.
9. A method according to claim 5, wherein the DNA to be analysed is provided with a protected amino group at the 5'-terminus, which group is deprotected and coupled to a dye molecule subsequent to the sequencing reactions.
10. A method according to any one of the preceding claims, wherein the four sets of DNA fragments which are produced in sequencing for A, C, G and T respectively carry different colored tags or different fluorescent tags and aliquots from each set are subjected to electrophoresis on the same gel.
11. A method according to claim 10, wherein the aliquots are combined and subjected to electrphoresis on the same gel.
12. A method according to claim 10 or 11, wherein the gel is a polyacrylamide gel.
13. A method according to any one of claims 1 to 4, wherein the sequencing is effected using the chain termination method, the respective primer oligonucleotides used in the sequencing reactions for A, C, G and
T have different colored tags and aliquots from the four sequencing reactions are combined and subjected to electrophoresis together on the same polyacrylamide gel.
14. A method according to any one of claims 1 to 4, wherein the sequencing is effected using the chain termination method, the respective primer oligonucleotides used in the sequencing reactions for A, C, G and
T have different fluorescent tags and aliquots from the four sequencing reactions are combined and subjected to electrophoresis together on the some polyacrylamide gel.
15. A method according to any one of claims 1 and 5 to 7, wherein the sequencing is effected using the chemical degradation method, the portions of DNA to be analysed in each chemical modification reaction are labelled with different colored tags and aliquots from the sequencing reactions are combined and subjected to electrophoresis together on the same polyacrylamide gel.
16. A method according to any one of claims 1 and 5 to 7, wherein the sequencing is effected using the chemical degradation method, the portions of DNAto be analysed in each chemical modification reaction are labelled with different fluorescent tags and aliquots from the sequencing reactions are combined and subjected electrophoresis together on the same polyacrylamide gel.
17. A method according to claim 8 or 9, wherein the products of each of the different sequencing reactions are coupled with a different color dye and aliquots of each dye-labelled product are combined and subjected to electrophoresis together on the same polyacrylamide gel and detected after their separation on the gel.
18. A method of sequencing DNA using DNA fragments labelled with a colored orfluorescenttag, said method being substantially as hereinbefore described.
19. A method of sequencing DNA substantially as herein before described with reference to any one of
Figures 1 to 6 of the accompanying drawings.
20. In the method of DNA sequencing by the chain termination method;
the improvement wherein the primer oligonucleotide is labeled with a colored tag.
21. In the method of DNA sequencing by the chain termination method;
the improvement wherein the primer oligonucleotide is labeled with a fluorescent tag.
22. In the method of DNA sequencing by the chemical degradation method;
the improvement wherein the DNA molecules are labeled with a colored tag.
23. In the method of DNA sequencing by the chemical degradation method;
the improvement wherein the DNA molecules are labeled with a fluorescent tag.
24. In the method of DNA sequencing by the chain termination method;
the improvement wherein the primer oligonucleotide used in each of the four sequencing reactions, A, C,
G and T, has a different colored tag attached to it, and wherein aliquots of the aforesaid sequencing reactions are combined and electrophoresced together on polyacrylamide gel and detected after their separation on the gel.
25. In the method of DNA sequencing by the chain termination method;
the improvement wherein the primer oligonucleotide used in each of the four sequencing reactions, A, C,
G and T, has a different fluorescent tag attached to it, and wherein aliquots of the aforesaid sequencing reactions are combined and electrophoresed together on polyacrylamide gel and detected after their separation on the gel.
26. In the method of DNA sequencing by the chemical degradation method;
the improvement wherein the DNA molecules are labeled with different colored tags, and a different colored DNA is used in each of the chemical modification reactions, and aliquots of the aforesaid sequencing reactions are combined and electrophoresed together on a polyacrylamide gel and detected after their separation of the gel.
27. In the method of DNA sequencing by the chemical degradation method;
the improvement wherein the DNA molecules are labeled with different fluorescent tags, and a different fluorescent DNA is used in each of the chemical modificiation reactions, and aliquots of the aforesaid sequencing reactions are combined and electrophoresed together on a polyacrylamide gel and detected after their separation of the gel.
28. In the method of DNA sequencing by the chemical degradation method;
the improvement wherein the DNA molecules are labeled with an amino group, which is coupled to a dye molecule subsequent to the sequencing reactions.
29. In the method of DNA sequencing of the chemical degradation method;
the improvement wherein the DNA molecules are labeled with a protected amino group which is deblocked and coupled to a dye molecule subsequent to the sequencing reactions.
30. In the method of claim 28, the further improvement wherein the products of each of the different sequencing reactions are coupled with a different color dye, aliquots of the dye labeled reaction are combined and electrophoresed on a polyacrylamide gel and detected after their separation on the gel.
31. In the method of claim 29, the further improvement wherein the products of each of the different sequencing reactions are coupled with a different color dye, aliquots of the dye labeled reaction are combined and electrophoresed on a polyacrylamide gel and detected after their separation on the gel.
32. A novel system for the analysis of DNA fragments comprising:
a source of chromophore or fluorescent tagged DNA fragments,
a zone for containing an electrophoresis gel,
means for introducing said tagged DNA fragments to said zone; and
photometric means for monitoring said tagged DNA fragments as they move through said gel.
33. The novel system of claim 32, wherein the photometric means is an absorption photometer.
34. The novel system of claim 32, wherein the photometric means is a fluorescent photometer.
35. The novel system of claim 32, wherein the DNA fragments are labeled with an amino group which is coupled to a dye molecule.
36. The novel system of claim 35 wherein the DNA fragments have different colored tags.
37. Apparatus according to claim 32 substantially as hereinbefore described.
38. Apparatus for the analysis of DNA fragments, said apparatus being substantially as hereinbefore
described in any one of Figures 2 to 4 or in Figure 6 of the accompanying drawings.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57097384A | 1984-01-16 | 1984-01-16 | |
US68901385A | 1985-01-02 | 1985-01-02 |
Publications (3)
Publication Number | Publication Date |
---|---|
GB8500960D0 GB8500960D0 (en) | 1985-02-20 |
GB2155176A true GB2155176A (en) | 1985-09-18 |
GB2155176B GB2155176B (en) | 1988-05-11 |
Family
ID=27075453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08500960A Expired GB2155176B (en) | 1984-01-16 | 1985-01-15 | Sequencing dna |
Country Status (5)
Country | Link |
---|---|
CA (1) | CA1258611A (en) |
DE (1) | DE3501306C2 (en) |
FR (1) | FR2558262B1 (en) |
GB (1) | GB2155176B (en) |
SE (1) | SE456348B (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0216905A1 (en) * | 1985-04-01 | 1987-04-08 | The Salk Institute For Biological Studies | Dna sequencing |
EP0252683A2 (en) * | 1986-07-02 | 1988-01-13 | E.I. Du Pont De Nemours And Company | Process and reagents for DNA sequence analysis |
US4811218A (en) * | 1986-06-02 | 1989-03-07 | Applied Biosystems, Inc. | Real time scanning electrophoresis apparatus for DNA sequencing |
US4855225A (en) * | 1986-02-07 | 1989-08-08 | Applied Biosystems, Inc. | Method of detecting electrophoretically separated oligonucleotides |
US5035863A (en) * | 1988-05-10 | 1991-07-30 | Amersham International Plc | Surface plasmon resonance sensors |
US5274240A (en) * | 1990-01-12 | 1993-12-28 | The Regents Of The University Of California | Capillary array confocal fluorescence scanner and method |
US5273638A (en) * | 1991-09-30 | 1993-12-28 | Beckman Instruments, Inc. | Nucleotide sequence determination employing matched dideoxynucleotide terminator concentrations |
US5292483A (en) * | 1991-06-28 | 1994-03-08 | Beckman Instruments, Inc. | Detecting a radiation signal |
US5436130A (en) * | 1992-03-19 | 1995-07-25 | The Regents Of The University Of California | Multiple tag labeling method for DNA sequencing |
US5484571A (en) * | 1991-10-08 | 1996-01-16 | Beckman Instruments, Inc. | Enhanced fluorescence detection of samples in capillary column |
WO2000040959A1 (en) * | 1999-01-08 | 2000-07-13 | Commonwealth Biotechnologies, Inc. | An automated dna sequencer loading dye which contains a lane tracking aid |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3618605A1 (en) * | 1986-06-03 | 1987-12-10 | Europ Lab Molekularbiolog | DEVICE FOR DETECTING SUBSTANCES INCENTIVELY TO PHOTON EMISSION |
DE3621631A1 (en) * | 1986-06-27 | 1988-01-14 | Hirschmann Geraetebau Gmbh & C | DEVICE FOR IMAGING AN OBJECT ON AN ELECTROOPTIC CONVERTER |
US5242796A (en) * | 1986-07-02 | 1993-09-07 | E. I. Du Pont De Nemours And Company | Method, system and reagents for DNA sequencing |
JPH0799353B2 (en) * | 1987-03-31 | 1995-10-25 | 株式会社島津製作所 | Nucleotide sequencer |
DE3752148T2 (en) * | 1987-06-09 | 1998-09-17 | Perkin Elmer Corp | Real time scanner in an electrophoresis apparatus for DNA sequence determination |
US4833332A (en) * | 1987-06-12 | 1989-05-23 | E. I. Du Pont De Nemours And Company | Scanning fluorescent detection system |
US5102785A (en) * | 1987-09-28 | 1992-04-07 | E. I. Du Pont De Nemours And Company | Method of gene mapping |
JPH01224657A (en) * | 1988-03-04 | 1989-09-07 | Hitachi Ltd | Nucleic acid base sequencing device |
SE8802573D0 (en) * | 1988-07-08 | 1988-07-08 | Wallac Oy | MULTI-LABEL TIME-RESOLVED FLUORESCENCE ANALYSIS OF NUCLEIC ACID SEQUENCES USING LANTHANIDE CHELATES |
FR2636739B1 (en) * | 1988-09-20 | 1993-02-12 | Commissariat Energie Atomique | METHOD AND INSTALLATION FOR IDENTIFYING THE BASES OF DNA |
FR2636738B1 (en) * | 1988-09-20 | 1992-12-11 | Commissariat Energie Atomique | DNA SEQUENCING PROCESS AND INSTALLATION |
US5061361A (en) * | 1989-03-06 | 1991-10-29 | Hewlett-Packard Company | Capillary zone electrophoresis cell system |
FR2649487B1 (en) * | 1989-06-21 | 1991-09-20 | Europhor Sa | ELECTROPHORESIS CAPILLARY WITH INCORPORATED OPTICAL DEVICE |
FR2671407B1 (en) * | 1991-01-08 | 1994-08-05 | Europhor Sa | METHOD OF ANALYSIS BY CAPILLARY ELECTROPHORESIS WITH FLUORESCENCE DETECTION, AND DEVICES FOR IMPLEMENTING SAME. |
EP0539743B1 (en) * | 1991-09-30 | 1997-08-06 | Beckman Instruments, Inc. | Enhanced fluorescence detection of samples in capillary column |
JPH05332992A (en) * | 1992-05-29 | 1993-12-17 | Shimadzu Corp | Electrophoresis device |
DE4336911C2 (en) * | 1993-10-28 | 2002-11-21 | Biotechnolog Forschung Gmbh | Primer production process and template bank therefor |
JP3068413B2 (en) * | 1994-07-13 | 2000-07-24 | 日立電子エンジニアリング株式会社 | DNA base sequencer |
US5675155A (en) * | 1995-04-26 | 1997-10-07 | Beckman Instruments, Inc. | Multicapillary fluorescent detection system |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983003260A1 (en) * | 1982-03-11 | 1983-09-29 | Per Artur Peterson | Method and probe for determination of tissue types coded by mhc genes |
EP0097341A1 (en) * | 1982-06-17 | 1984-01-04 | Imreg, Inc. | Sensitive tests for malignancies based on DNA detection |
EP0070687B1 (en) * | 1981-07-17 | 1985-10-16 | Amoco Corporation | Light-emitting polynucleotide hybridization diagnostic method |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1205028A (en) * | 1981-07-01 | 1986-05-27 | Jerald C. Hinshaw | Fluorescent chelates and labeled specific binding reagents prepared therefrom |
FR2519005B1 (en) * | 1981-12-29 | 1985-10-25 | Pasteur Institut | DNA FRAGMENTS MARKED WITH AT LEAST ONE OF THEIR ENDS ENDANGERED BY MODIFIED RIBONUCLEOTIDES RECOGNIZABLE BY AFFINOUS MOLECULES AND METHOD FOR CARRYING OUT ANALYSIS OF SUCH DNA FRAGMENTS |
-
1985
- 1985-01-15 GB GB08500960A patent/GB2155176B/en not_active Expired
- 1985-01-15 CA CA000472103A patent/CA1258611A/en not_active Expired
- 1985-01-16 SE SE8500201A patent/SE456348B/en not_active IP Right Cessation
- 1985-01-16 FR FR8500597A patent/FR2558262B1/en not_active Expired
- 1985-01-16 DE DE19853501306 patent/DE3501306C2/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0070687B1 (en) * | 1981-07-17 | 1985-10-16 | Amoco Corporation | Light-emitting polynucleotide hybridization diagnostic method |
WO1983003260A1 (en) * | 1982-03-11 | 1983-09-29 | Per Artur Peterson | Method and probe for determination of tissue types coded by mhc genes |
EP0097341A1 (en) * | 1982-06-17 | 1984-01-04 | Imreg, Inc. | Sensitive tests for malignancies based on DNA detection |
Non-Patent Citations (2)
Title |
---|
MAXAM AND GILBERT, METHODS IN ENZYMOLOGY, 65, 499-559 (1980) * |
SANGER ET, AL. PROC. NATL. ACAD. SCI. USA 74, 5463 (1977) * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0216905A1 (en) * | 1985-04-01 | 1987-04-08 | The Salk Institute For Biological Studies | Dna sequencing |
EP0216905A4 (en) * | 1985-04-01 | 1988-09-07 | Salk Inst For Biological Studi | Dna sequencing. |
US4855225A (en) * | 1986-02-07 | 1989-08-08 | Applied Biosystems, Inc. | Method of detecting electrophoretically separated oligonucleotides |
US4811218A (en) * | 1986-06-02 | 1989-03-07 | Applied Biosystems, Inc. | Real time scanning electrophoresis apparatus for DNA sequencing |
EP0252683A2 (en) * | 1986-07-02 | 1988-01-13 | E.I. Du Pont De Nemours And Company | Process and reagents for DNA sequence analysis |
EP0252683A3 (en) * | 1986-07-02 | 1989-11-23 | E.I. Du Pont De Nemours And Company | Method, system and reagents for dna sequencing |
US5035863A (en) * | 1988-05-10 | 1991-07-30 | Amersham International Plc | Surface plasmon resonance sensors |
US5274240A (en) * | 1990-01-12 | 1993-12-28 | The Regents Of The University Of California | Capillary array confocal fluorescence scanner and method |
US5292483A (en) * | 1991-06-28 | 1994-03-08 | Beckman Instruments, Inc. | Detecting a radiation signal |
US5273638A (en) * | 1991-09-30 | 1993-12-28 | Beckman Instruments, Inc. | Nucleotide sequence determination employing matched dideoxynucleotide terminator concentrations |
US5484571A (en) * | 1991-10-08 | 1996-01-16 | Beckman Instruments, Inc. | Enhanced fluorescence detection of samples in capillary column |
US5436130A (en) * | 1992-03-19 | 1995-07-25 | The Regents Of The University Of California | Multiple tag labeling method for DNA sequencing |
WO2000040959A1 (en) * | 1999-01-08 | 2000-07-13 | Commonwealth Biotechnologies, Inc. | An automated dna sequencer loading dye which contains a lane tracking aid |
Also Published As
Publication number | Publication date |
---|---|
DE3501306C2 (en) | 1998-09-24 |
DE3501306A1 (en) | 1985-07-25 |
FR2558262B1 (en) | 1989-04-07 |
SE8500201D0 (en) | 1985-01-16 |
SE456348B (en) | 1988-09-26 |
SE8500201L (en) | 1985-07-17 |
GB2155176B (en) | 1988-05-11 |
GB8500960D0 (en) | 1985-02-20 |
CA1258611A (en) | 1989-08-22 |
FR2558262A1 (en) | 1985-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1258611A (en) | Method of dna sequencing | |
US6200748B1 (en) | Tagged extendable primers and extension products | |
US5171534A (en) | Automated DNA sequencing technique | |
US5728529A (en) | Alternative dye-labeled ribonucleotides, deoxyribonucleotides, and dideoxyribonucleotides for automated DNA analysis | |
US5317098A (en) | Non-radioisotope tagging of fragments | |
Trainor | DNA sequencing, automation, and the human genome | |
US6544744B1 (en) | Probes labeled with energy transfer coupled dyes | |
JP3066984B2 (en) | General-purpose spacer / energy transition dye | |
EP0943019B1 (en) | Sets of labeled energy transfer fluorescent primers and their use in multi component analysis | |
EP0381693B1 (en) | Method for rapid base sequencing in dna and rna | |
US5427911A (en) | Coupled amplification and sequencing of DNA | |
EP0233053B1 (en) | Method of detecting electrophoretically separated oligonucleotides | |
JP2003504619A (en) | Increased throughput analysis of small compounds using multiple injections spaced in time | |
JP2628571B2 (en) | Oligonucleotide analyzer | |
EP0542883B1 (en) | Method for determining dna sequences | |
AU670622B2 (en) | Digital DNA typing | |
JPS61173158A (en) | DNA sequencing | |
Yang et al. | A prospectus for multispectral-multiplex DNA sequencing | |
USRE43096E1 (en) | Tagged extendable primers and extension products | |
US5549805A (en) | Digital DNA typing | |
US5863403A (en) | Digital DNA typing | |
Tong et al. | Combinatorial fluorescence energy transfer tags: New molecular tools for genomics applications | |
Bhat et al. | DNA Sequencing | |
Soper et al. | DNA sequencing using fluorescence detection | |
JP2649794C (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE20 | Patent expired after termination of 20 years |
Effective date: 20050114 |